Rehabilitation and COVID-19: a rapid living systematic review 2020 by Cochrane Rehabilitation Field. Update as of October 31st, 2020

Andrenelli, Elisa; Negrini, Francesco; Sire, Alessandro de; Patrini, Michele; Lazzarini, Stefano Giuseppe; Ceravolo, Maria Gabriella

doi:10.23736/s1973-9087.20.06723-4

Cited by 32 publications

(12 citation statements)

References 25 publications

(113 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evidence from high-quality trials on the effectiveness of such programmes in COVID-19 survivors is, however, lacking to date. 11 Moreover, delivery of conventional inpatient or outpatient rehabilitation is complicated through diminished capacity in postacute care as well as clinical and public health measures imposed to reduce the risk of viral transmission. 12 Telerehabilitation provides a viable alternative that could be superior to no rehabilitation and as effective as conventional rehabilitation.…”

Section: Introductionmentioning

confidence: 99%

A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial

Xia

Zhan³

et al. 2021

Thorax

183

316

View full text Add to dashboard Cite

ObjectivesTo investigate superiority of a telerehabilitation programme for COVID-19 (TERECO) over no rehabilitation with regard to exercise capacity, lower limb muscle strength (LMS), pulmonary function, health-related quality of life (HRQOL) and dyspnoea.DesignParallel-group randomised controlled trial with 1:1 block randomisation.SettingThree major hospitals from Jiangsu and Hubei provinces, China.Participants120 formerly hospitalised COVID-19 survivors with remaining dyspnoea complaints were randomised with 61 allocated to control and 59 to TERECO.InterventionUnsupervised home-based 6-week exercise programme comprising breathing control and thoracic expansion, aerobic exercise and LMS exercise, delivered via smartphone, and remotely monitored with heart rate telemetry.OutcomesPrimary outcome was 6 min walking distance (6MWD) in metres. Secondary outcomes were squat time in seconds; pulmonary function assessed by spirometry; HRQOL measured with Short Form Health Survey-12 (SF-12) and mMRC-dyspnoea. Outcomes were assessed at 6 weeks (post-treatment) and 28 weeks (follow-up).ResultsAdjusted between-group difference in change in 6MWD was 65.45 m (95% CI 43.8 to 87.1; p<0.001) at post-treatment and 68.62 m (95% CI 46.39 to 90.85; p<0.001) at follow-up. Treatment effects for LMS were 20.12 s (95% CI 12.34 to 27.9; p<0.001) post-treatment and 22.23 s (95% CI 14.24 to 30.21; p<0.001) at follow-up. No group differences were found for lung function except post-treatment maximum voluntary ventilation. Increase in SF-12 physical component was greater in the TERECO group with treatment effects estimated as 3.79 (95% CI 1.24 to 6.35; p=0.004) at post-treatment and 2.69 (95% CI 0.06 to 5.32; p=0.045) at follow-up.ConclusionsThis trial demonstrated superiority of TERECO over no rehabilitation for 6MWD, LMS, and physical HRQOL.Trial registration numberChiCTR2000031834.

show abstract

Section: Introductionmentioning

confidence: 99%

A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial

Xia

Zhan³

et al. 2021

Thorax

183

316

View full text Add to dashboard Cite

show abstract

“…Current evidence for rehabilitation after COVID-19 is weak but steadily increasing [78]. Clinical trials are ongoing to evaluate the effects of pulmonary rehabilitation after COVID-19 [11].…”

Section: Results Of the Swiss National Survey Among Pulmonologistsmentioning

confidence: 99%

Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID

et al. 2021

View full text Add to dashboard Cite

Introduction: Emerging evidence suggests that long-term pulmonary symptoms and functional impairment occurs in a proportion of individuals following SARS-CoV-2 infection. Although the proportion of affected patients remains to be determined, physicians are increasingly being confronted with patients reporting respiratory symptoms and impairment beyond the acute phase of COVID-19. In face of limited evidence, the Swiss Society for Pulmonology established a working group to address this area of unmet need and formulated diagnostic and treatment recommendations for the care of patients with pulmonary long COVID (LC). Method: The Swiss COVID Lung Study group and Swiss Society for Pulmonology (SSP) formulated 13 questions addressing the diagnosis and treatment of pulmonary LC. A survey within the SSP special interest groups involved in care of LC patients was conducted in Switzerland. A CORE process/Delphi-like process was used to formulate recommendations. Forty experienced pulmonologists replied to the first survey and 22 completed the second follow-up survey. Agreement of ≥70% consensus led to formulation of a recommendation. Results: The participants in the survey reached consensus and formulated a strong recommendation for regarding the following points. Patients hospitalized for COVID-19 should have a pulmonary assessment including pulmonary function tests. Symptomatic subjects affected by COVID-19, including those with mild disease, should benefit from a pulmonary follow-up. Persistent respiratory symptoms after COVID-19 should be investigated by a pulmonary follow-up including plethysmography, diffusion capacity measurement, and blood gases analysis. Individuals having suffered from COVID-19 and who present with persistent respiratory symptoms should be offered a rehabilitation. Additional questions were given moderateor weak recommendations for. The panel did not reach sufficient consensus for pharmacological therapy (e.g., therapy specifically targeting lung fibrosis) to formulate recommendations for LC drug treatment. Conclusion: The formulated recommendations should serve as an interim guidance to facilitate diagnosis and treatment of patients with pulmonary LC. As new evidence emerges, these recommendations may need to be adapted.

show abstract

“…This was later confirmed by other authors, indicating that in patients who have recovered from Covid-19, the physical and functional impairment can persist for weeks after hospital discharge, as can some symptoms (such as dyspnea, desaturation, coughing, weakness and fatigue). In addition to the damage caused by prolonged hospitalisation and inactivity, the persistent high inflammatory burden and previous health conditions seem to have a negative influence on the recovery of these patients (Santana et al, 2021;Spruit et al, 2020;DeLorenzo et al, 2020;Negrini et al, 2020). The problem is also that in Poland, the post-Covid rehabilitation system is very diverse, and its financing and organisation are handled by the National Health Fund (NFZ), the Social Insurance Institution (ZUS), the Agricultural Health Insurance Fund (KRUS), the State Fund for the Rehabilitation of Disabled Persons (PFRON), and local governments.…”

Section: Discussionmentioning

confidence: 99%

The Results of Post-Covid Rehabilitation in Pulmonary Care Patients

Witana-Hebda¹,

Pietrzykowska²

2022

Regional Formation and Development Studies

View full text Add to dashboard Cite

Post-Covid rehabilitation deals with properly selected exercises for the respiratory muscles, respiratory rehabilitation, learning to relax, and exercise. The aim of the study was to evaluate the results of post-Covid rehabilitation in pulmonary care patients. The study was performed on a group of 50 patients (15 women, 35 men; the mean age was 59.4 years) undergoing pulmonary rehabilitation in January 2022 in the rehabilitation department of a pulmonary hospital in southern Poland. Patients’ physical activity tolerance was assessed before and after rehabilitation using the walk test, mMRC test, Barthel’s scale, CAT questionnaire and Borg’s scale. The research results show a statistically significant improvement in all patients and in each of the methods for assessing physical activity tolerance. There is an urgent need for a rehabilitation programme aimed specifically at post-Covid patients.

show abstract

Rehabilitation and COVID-19: a rapid living systematic review 2020 by Cochrane Rehabilitation Field. Update as of October 31st, 2020

Cited by 32 publications

References 25 publications

A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial

A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial

Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID

The Results of Post-Covid Rehabilitation in Pulmonary Care Patients

Contact Info

Product

Resources

About